the market?
Medivation, Inc.
NASDAQ: MDVN
47.53
-0.76
(-1.57%)
| Today's Open | $48.38 |
|---|---|
| Previous Close | $48.29 |
| Daily Range | $47.27 - $48.99 |
| 52-Week Range | $39.36 - $59.24 |
| Market Cap | $3.6B |
| P/E Ratio | -51.92 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,324,600 |
| Average Daily Volume | 1,019,668 |
| Current FY EPS | -$1.04 |
How do you think MDVN
will perform against the market?
Top MDVN Bull/Bear Pitches
zzlangerhans (< 20)
Submitted
August 25, 2011
Hopefully Dimebon has now provided enough failures to reduce its contribution to Medivation's enterprise value to zero. The new central story is the promising prostate cancer drug MDV3100 . In June th … More
KurtEng (< 20)
Submitted
August 17, 2011
I would never put my own money into this stock. They will have to grow like crazy to justify the current price and so far they haven't generated any positive cash flow. The downside seems huge.
News & Commentary
The 8 Biggest Health Problems Americans Face
What health problems do Americans think are most significant? Some of the answers might be surprising.Dendreon: Picking Through the Carnage
First-quarter results for the prostate cancer drug maker were even uglier than anticipated.3 Horrendous Health-Care Stocks This Week
These three health-care stocks were party-poopers this week as investors celebrated the market hitting all-time highs, yet again.This Biotech Is Looking for a Fourth-Quarter Comeback
After a crummy quarter, Dendreon looks to ramp up salesWhy Dendreon Had Its Battleship Sunk
Increasing competition and a lack of love from the insurance industry sinks Dendreon's chances of a decent quarter.Will Dendreon Ever Make Money?
The drug company's big blockbuster hasn't turned out so well.This Week's Must-Watch Stock: Dendreon
Dendreon has set expectations low for the quarter, can they surprise investors?Europe Hands Down 2 Critical Drug Decisions
Medivation's Xtandi get a thumbs up, while Pfizer's Xeljanz gets a thumbs down.Sector
Healthcare
Industry
Drugs
Medivation, Inc. (MDVN) Description
A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies. Website: http://www.medivation.net/
CEO Rating by Glassdoor
More details for Medivation Jobs
Medivation reviews from employees
